Discover 2,226 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,226
Erector Spinae Plane Blockade in Pediatric Scoliosis Surgery Patients
for
Scoliosis; Juvenile, Scoliosis; Adolescence
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 0 - 18
Code: NCT04153994
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Oakland CA, Sacramento CA, Los Angeles CA, Duarte CA,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase3, Recruiting
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Location: Palo Alto CA, Irvine CA, Seattle WA, St Louis MO,
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06745076
Phase2, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Redwood City CA, Stanford CA, Napa CA, Salinas CA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
US National TOP Registry
for
Lung Transplant
Location: Stanford CA, Phoenix AZ, Dallas TX, Minneapolis MN,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT06513091
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: San Francisco CA, Oakland CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
SWIFT Study in the ED
for
Mild Traumatic Brain Injury
Location: San Francisco CA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT01893970
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Stanford CA, La Jolla CA, Portland OR, Phoenix AZ,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase2, Recruiting
TVMR With the INNOVALVE System Trial - Early Feasibility Study
for
Mitral Valve Regurgitation (Degenerative or Functional)
Location: Palo Alto CA, Los Angeles CA, Portland OR, Seattle WA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 18+
Code: NCT04919980
Recruiting
Prehospital Analgesia INtervention Trial (PAIN)
for
Traumatic Injury
Location: San Francisco CA, San Diego CA, Salt Lake City UT,
Sponsor: Jason Sperry
Sex: All
Age: 18+
Code: NCT05437575
Phase3, Recruiting
Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies
for
Solid Tumor, Adult
Location: Palo Alto CA, Los Angeles CA, Houston TX,
Sponsor: Effector Therapeutics
Sex: All
Age: 18+
Code: NCT04092673
Phase1, Phase2, Recruiting
Prehabilitation and Rehabilitation in PAD
for
Peripheral Arterial Disease
Location: Palo Alto CA
Sponsor: Palo Alto Veterans Institute for Research
Sex: All
Age: 18+
Code: NCT06566976
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Palo Alto CA, Los Angeles CA, Inglewood CA, Pomona CA,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
Comparison of Standard and Endoscope Assisted Endotracheal Intubation
for
Biliary Tract Diseases, Pancreatic Diseases
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 0+
Code: NCT03879720
Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG